Mersana Therapeutics, Inc. (MRSN)

NASDAQ: MRSN · Real-Time Price · USD

7.14

-0.33 (-4.42%)

At close: Sep 12, 2025, 4:00 PM EDT

7.25

+0.11 (1.54%)

After-hours: Sep 12, 2025, 7:38 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Antibody-drug Conjugates	40.50M	Log In	Log In	Log In	Log In	Upgrade
Antibody-drug Conjugates Growth	9.88%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	40.50M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	9.88%	Log In	Log In	Log In	Log In	Upgrade